Douglas Quinton Larson Net Worth

Mr. Douglas Quinton Larson biography

Douglas Quinton Larson is the CFO, Principal Financial Officer & Principal Accounting Officer at Beyond Air.

How old is Mr Larson?

Mr Larson is 50, he's been the CFO and Principal Financial Officer & Principal Accounting Officer of Beyond Air since . There are 7 older and 4 younger executives at Beyond Air. The oldest executive at Beyond Air, Inc. is Michael A. Gaul, 65, who is the Sr. VP of Operations.

What's Mr Larson's mailing address?

Douglas's mailing address filed with the SEC is C/O BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY, NY, 11530.

Insiders trading at Beyond Air

Over the last 5 years, insiders at Beyond Air have traded over $4,582,444 worth of Beyond Air stock and bought 3,519,117 units worth $12,396,434 . The most active insiders traders include Robert Carey, Steven A. Lisi, and Amir Avniel. On average, Beyond Air executives and independent directors trade stock every 17 days with the average trade being worth of $15,492. The most recent stock trade was executed by Steven A. Lisi on 15 August 2024, trading 50,000 units of XAIR stock currently worth $18,500.

What does Beyond Air do?

Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Beyond Air executives and stock owners

Beyond Air executives and other stock owners filed with the SEC include:

• Steven Lisi,
  Chairman of the Board, Chief Executive Officer
• Amir Avniel,
  President, Chief Operating Officer, Director
• Adam Newman,
  Chief Legal Officer and General Counsel
• Steven Adam Lisi,
  CEO & Chairman
• Duncan Fatkin,
  Chief Commercial Officer
• Douglas Beck,
  Chief Financial Officer
• Amir Avniel,
  Co-Founder, Pres, COO & Director
• Douglas J. Beck CPA, CPA,
  Consultant
• William Forbes,
  Independent Director
• Erick Lucera,
  Independent Director
• Robert Carey,
  Independent Director
• Yoori Lee,
  Independent Director
• Ron Bentsur,
  Independent Director
• Bob Yedid,
  IR Contact Officer
• Prof. Andrew R. Colin M.D.,
  Chief Medical Officer & Member of Scientific Advisory Board
• Kori-Ann Taylor,
  Head of Marketing
• Rebecca Van Doren,
  Head of Sales
• Maria Yonkoski,
  Head of Investor Relations
• Douglas Quinton Larson,
  CFO, Principal Financial Officer & Principal Accounting Officer
• Hila Confino Ph.D.,
  Research Project Mang.
• Michael A. Gaul,
  Sr. VP of Operations
• Ali Ardakani,
  Sr. VP of Device & Bus. Devel.
• Dr. Giora Davidai M.D.,
  Chief Medical Officer
• Douglas Quinton Larson,
  Chief Financial Officer
• Michael A. Gaul,
  Chief Operating Officer
• Jeff Lynn Myers,
  Chief Medical Officer